Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-29
2007-05-29
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S422000, C514S326000, C514S329000, C514S444000, C514S378000, C514S360000, C514S364000, C514S381000, C546S209000, C546S210000, C546S212000, C546S224000, C548S254000, C548S266600, C548S518000, C548S247000, C549S060000, C549S081000
Reexamination Certificate
active
10848916
ABSTRACT:
The present invention is directed to the compound of formula I which is useful for inhibiting the activity of blood clotting enzyme Factor Xa. The present invention is also directed to compositions containing said compounds, processes for their preparation, their use, such as for inhibiting the formation of thrombin or for therapeutically treating a patient suffering from, or subject to, a disease state associated with a cardiovascular disorder.
REFERENCES:
patent: 5525733 (1996-06-01), Novack et al.
patent: 5998424 (1999-12-01), Galemmo, Jr. et al.
patent: 6020357 (2000-02-01), Pinto et al.
patent: 6339099 (2002-01-01), Lam et al.
patent: 6906084 (2005-06-01), Nazaré et al.
patent: 6953857 (2005-10-01), Nazaré et al.
patent: 7067665 (2006-06-01), Nazaré et al.
patent: 2002/0091116 (2002-07-01), Zhu et al.
patent: 2004/0106614 (2004-06-01), Lange et al.
patent: 2004/0171604 (2004-09-01), Nazaré et al.
patent: 2004/0204406 (2004-10-01), Nazaré et al.
patent: 2004/0235824 (2004-11-01), Nazaré et al.
patent: 2005/0009829 (2005-01-01), Nazaré et al.
patent: 2005/0033049 (2005-02-01), Nazaré et al.
patent: 2005/0043302 (2005-02-01), Nazaré et al.
patent: 0987274 (2000-03-01), None
patent: WO 92/06711 (1992-04-01), None
patent: WO 95/29189 (1995-11-01), None
patent: WO 96/12800 (1996-05-01), None
patent: WO 97/47651 (1997-12-01), None
patent: WO 99/32454 (1999-07-01), None
patent: WO 01/07436 (2001-02-01), None
patent: WO 01/32628 (2001-05-01), None
patent: WO 02/00651 (2002-01-01), None
STN search results of Chemical Abstract of Indian Journal of Chemistry, Section B, 1976, 14B(10), 744-6, Harhash, et al.
Farag et al. Chem. Research, 1994, p. 10-11.
Adang, et al., A New Generation Of Orally Active Antithrombotics: Comparing Strategies in the GPIIb/IIa, Thrombin and Factor Xa Areas, Drugs of the Future 2000, 25(4) 369-383.
Altural, et al., Preparation And Some Simple Reactions Of 1-Substituted Imidazole-2,4,5-Triones, Organic Preparation and Procedures Int., 23(2), 147-151 (1991).
Artico, et al., Aromatic hydrazides As Specific Inhibitors Of Bovine Serum Amine Oxidase, Eur. J. Med. Chem. Chim. Ther. (1992), 27, 219-228.
Bruche, et al., An Improved Synthesis of 1H-1,2,4-Triazoles from C-Triphenylphosphinimino-Hydrazones, Synthesis (1986) 9, 772-774.
Butler, et al., New General Methods For The Substitution Of 5-Chloropyrazoles. The Synthesis Of 1,3-Dialkyl-5-Chloropyrazol-4-yl Aryl Ketones And New 1,3-Dialkyl-2-Pyrazolin-5-Ones, J. Org. Chem. (1971) 36, 2542-2547.
Cerrada, et al., Synthesis Of p-Nitrophenylazoles By Phase Transfer Catalysis Without Solvent, Synthetic Communications, (1993), 23(14), 1947-1952.
Chan, et al., New N- And O-Arylations Wth Phenylboronic Acids And Cupric Acetate, Tetrahedron Letters 39 (1998) 2933-2936.
Cheng, et al., Relationship Between The Inhibition Constant (KI) And The Concentration Of Inhibitor Which Causes 50 Per Cent Inhibition (I50) Of An Enzymatic Reaction, Biochem. Pharmacol. 22 (1973) 3099-3108.
Collot, et al., First Combined Selective N-and C-Arylations With Boronic Acids: Application To The Synthesis Of 1,3-Diarylindazoles, Tetrahedron Letters 41 (2000) 9053-9057.
Cooper, et al., 1,4-Dihydropyridines As Antagonists Of Platelet Activating Factor. 1. Synthesis And Structure-Activity Relationships Of 2-(4-Heterocyclyl) Phenyl Derivatives, J. Med. Chem. (1992), 35, 3115-3129.
Cozzi, et al., Ethyl 2-{[5,6-Dihydro-7-(1H-Imidazol-1-YL)2-Naphthalenyl] Oxy}-2-Methylpropanoate As A New Potent Oxyisobutyrate Hypolipidaemic With Unusual Features, Farmaco (1987) 42, 205-218.
Danoun, et al., Etude De La Reactivite De Nitriles Vis-A-Vis Du Diazomethane: Synthese Et Etude Structurale De N-Methyl-V-Triazoles, Bull. Soc. Chim. Fr. (1995) 132, 943-951.
Duncia, et al., Three Synthetic Routes To A Sterically Hindered Tetrazole. A New One-Step Mild Conversion Of An Amide Into A Tetrazole, J. Org. Chem. (1991) 56, 2395-2400.
El-Ahl, et al., A Novel Approach For the Synthesis Of 5-Substituted Tetrazole Derivatives From Primary Amides In Mild One-Step Method, Tetrahedron Letters, vol. 38, No. 7, pp. 1257-1260. 1997.
Fleisher, et al., Improved Oral Drug Delivery: Solubility Limitations Overcome By The Use Of Prodrugs, Advanced Drug Delivery Reviews 19 (1996) 115-130.
Fusco, et al., Reaktionen Von Arylsulfonylaziden Mit Enaminen Aus Ketomethylenverbindungen, Chem. Ber. (1963) 96, 802-812.
Gardner et al., A Versatile Approach To Analogues Of The Cannabinoid-like Anti-emetic Nonabine (BRL 4664), J. Heterocycl. Chem. (1984), 21, 121-127.
Grimmett, et al., Synthesis And Reactions Of Lithiated Monocyclic Azoles Containing Two Or More Hetero-Atoms. Part III. Pyrazoles, Heterocycles (1994) 37, 2087-2147.
Hartwig, John, Ubergangsmetall-Katalysierte Synthese Von Arylaminen Und Arylethern Aus Arylhalogeniden Und—Triflaten: Anwendungen Und Reaktionsmechanismus, Angew. Chem. 110 (1998) 2154-2177.
Hartwig, et al., Room-Temperature Palladium-Catalyzed Amination Of Aryl Bromides And Chlorides And Extended Scope Of Aromatic C-N Bond Formation With A Commercial Ligand, J. Org. Chem. (1999), 64, 5575-5580.
Huisgen, et al., 1.3-Dipolare Additionen, II Synthese Von 1.2.4-Triazolen Aus Nitriliminen Und Nitrilen, Liebigs Ann. Chem. (1963) 653, 105.
Hans Bundgaard, Novel Chemical Approaches in Prodrug Design, Drugs Of The Future 1991, 16(5): 443-458.
Dehne, Heinz 1,2,3-Triazole, Methoden Der Organischen Chemie (Methods of Organic Chemistry), Georg Thieme Verlag, Stuttgart, Germany, 1994, vol. E8d Hetarene III, 305-405.
Kang, et al., Copper-Catalyzed N-Arylation Of Aryl Iodides With Benzamides Or Nitrogen Heterocycles In the Presence Of Ethylenediamine, Synlett (2002) 3, 427-430.
Klapars, et al., A General and Efficient Copper Catalyst For the Amidation Of Aryl Halides And The N-Arylation Of Nitrogen Heterocycles, J. Am. Chem. Soc. (2001), 123, 7727-7729.
Kwong, et al., Cooper-Catalyzed Coupling Of Alkylamines And Aryl Iodides: An Efficient System Even In An Air Atmosphere, Organic Letters (2002) vol. 4 (4) 581-584.
Lam, et al., Copper-Catalyzed General C-N And C-O Bond Cross-Coupling With Arylbornonic Acid, Tetrahedron Letters 42 (2001) 3415-3418.
Lam, et al., New Aryl/Heteroaryl C-N Bond Cross-Coupling Reactions Via Arylboronic Acid/Cupric Acetate Arylation, Tetrahedron Letters 39 (1998) 2941-2944.
Makino, et al., Selective Fluorination Of Ehtyl 1-Methylpyrazole-4-Carboxylates With Poly (Hydrogen Fluoride)—Amine Complex Under Electrolyic Anodic Oxidation, Journal Of Fluorine Chemistry, (1988), 39, 435-440.
Mann, et al., Palladium-Catalyzed C-N(sp2) Bond Formation: N-Arylation Of Aromatic And Unsaturated Nitrogen And The Reductive Elimination Chemistry Of Palladium Azolyl And Methyleneamido Complexes, J. Am. Chem. Soc. (1998), 120, 827-828.
Meier, et al., Tetrazole, Methoden Der Organischen Chemie (Methods of Organic Chemistry) Georg Thieme Verlag, Stuttgart, Germany 1994, vol. E8d Hetarene III, 664-794.
Murray-Rust, et al., An Expeditious Synthesis Of 4-Alkoxycarbonyl-5-Hydroxy-1,2,3-Triazoles: The Crystal And Molecular Structure Of The 2-Thienylammonium Salt Of 5-Hydroxy-4-Methoxycarbonyl-1-(2-thienyl)-1,2,3-Triazole, J. Chem. Soc. Perkin Trans. I (1984) 713-716.
Nachbaur, et al., 1,2,4-Triazole, Methoden der Organischen Chemie (Methods of Organic Chemistry), Georg Thieme Verlag, Stuttgart, Germany 1994, vol. E8d Hetarene III, 479-597.
Nichols, et al., 1-(2,5-Dimethoxy-4-(Trifluromethyl) Phenyl)-2-Aminopropane: A Potent Serotonin 5-HT2A/2C Agonist, J. Med Chem. (1994), 37, 4346-4351.
Old, et al., Efficient Palladium-Catalyzed N-Arylation Of Indoles, Organic Letters (2000) vol. 2, No. 10, 1403-1406.
Ostrem, et al., Discovery Of A Novel, Potent, And Specific Family Of Factor Xa Inhibitors Via Combinatorial Chemistry, Biochemistry (1998), 37, 1053-1059.
Pedersen, Christian, Rearrangement Of 4-Phenylazo-5-Hydroxy-1,2,3-Triazoles To Amides Of 2-Phenyl-5-Carboxytetrazole, Acta Chem. Scand. (1958) 12, 1236.
Qing, et al., First Synthesis Of Ortho-Trifluoromethylated Aryl Triflates, J. Chem. Soc. Perkin Trans I (1997) 3053-3057.
Sakamoto,
Bauer Armin
Laux Volker
Nazare Marc
Wagner Michael
Chu Yong
Knight Julie Anne
Lin Jiang
Rossi Joseph D.
Saeed Kamal A.
LandOfFree
Triazole-derivatives as blood clotting enzyme factor Xa... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole-derivatives as blood clotting enzyme factor Xa..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole-derivatives as blood clotting enzyme factor Xa... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3813158